Animal Health Market Size is valued at USD 62.3 Bn in 2024 and is predicted to reach USD 128.7 Bn by the year 2034 at an 7.5% CAGR during the forecast period for 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/2929
The animal healthcare industry comprises a comprehensive array of solutions—including pharmaceuticals, vaccines, medicated feeds, and diagnostic technologies—designed to prevent, diagnose, and treat diseases in animals. Animals serve a vital role in human life by providing companionship, ensuring food security, supporting livelihoods, and contributing to biomedical research through their use in drug development and genetic studies. Key factors driving the global veterinary healthcare market include increasing awareness of zoonotic diseases, strengthened regulatory frameworks, and heightened efforts to control infectious disease outbreaks.
Rising global consumption of animal-derived proteins and other food products underscores the growing need for a resilient animal health ecosystem. In response, stakeholders across the industry are prioritizing the development of advanced therapeutic options to address the increasing prevalence of animal diseases. Pharmaceutical companies have introduced a broad range of vaccines targeting critical health conditions affecting both livestock and companion animals. Simultaneously, various sectors are implementing rigorous biosecurity protocols aimed at minimizing the spread of pathogens and preventing foodborne illnesses.
The COVID-19 pandemic had a significant influence on the veterinary healthcare market by raising public and industry awareness around disease prevention, leading to a sustained increase in demand for related products and services. Reflecting ongoing consolidation and strategic realignment within the sector, Zoetis Inc. and Phibro Animal Health Corporation announced a $350 million agreement in April 2024. Under this deal, Phibro will acquire Zoetis’ medicated feed additive portfolio, select water-soluble products, and associated assets. The transaction is anticipated to close in the second half of 2024, subject to customary regulatory approvals and closing conditions.
Current industry trends highlight an increasing emphasis on preventive care strategies for both livestock and companion animals. Owners and producers are progressively adopting early detection tools and proactive health interventions to enhance animal welfare and mitigate disease risks. Concurrently, innovations in biotechnology and pharmaceutical sciences—such as DNA sequencing, PCR diagnostics, gene editing, and cell-based therapies—are reshaping veterinary medicine. These advancements enable the development of precision treatments, targeted vaccines, and sophisticated diagnostic tools tailored to specific species and conditions. Leading pharmaceutical companies are making substantial investments in R&D to deliver safer, more effective, and species-specific veterinary healthcare solutions.
List of Prominent Players in the Animal Health Market:
- Virbac S.A.
- NEOGEN Corporation
- Zoetis Inc.
- Vetoquinol S.A.
- Dechra Pharmaceuticals plc
- Mars Inc.
- Animalcare Group plc
- Bimeda
- Biognesis Bag
- Bioveta
- China Animal Husbandry Industry Company
- Chanelle
- ImmuCell Corporation
- Laboratorios CALIER, S.A
- HIPRA, S.A.
- Norbrook Laboratories
- Alembic Animal Health
- Boehringer Ingelheim GmbH
- Elanco
- IDEXX Laboratories, Inc.
- Ceva Santé Animale
- Merck & Co Inc.
Market Dynamics
Drivers:
The animal healthcare industry is experiencing significant growth, primarily fueled by an increasing number of pet owners, particularly among Millennial and Generation Z demographics. These consumer groups are contributing to the rising demand for advanced pet care products and technologies that focus on health, safety, and overall well-being. Concurrently, the escalating global demand for animal-derived food products—such as meat, dairy, and eggs—is prompting increased investment in livestock health. This includes expanded use of vaccination programs, feed additives, and preventive healthcare solutions. Moreover, stricter regulatory oversight related to animal welfare and food safety is encouraging the widespread adoption of vaccines, antimicrobial alternatives, and comprehensive disease management protocols across both companion and production animals.
Challenges:
Despite favorable market conditions, the sector faces regulatory and economic constraints that may hinder growth. One of the primary obstacles is the complex and time-consuming drug approval process, particularly in markets such as the United States, where veterinary pharmaceuticals are regulated by the U.S. Food and Drug Administration (FDA). According to the Animal Health Institute, the development of a new veterinary drug typically requires over a decade and can cost more than USD 100 million. Furthermore, the high costs associated with advanced diagnostics, treatments, and veterinary services restrict access to quality animal healthcare in emerging markets, thereby limiting potential expansion in those regions.
Regional Trends:
North America is projected to maintain its leadership position in the global animal healthcare market throughout the forecast period. This can be attributed to strong government-backed initiatives aimed at improving animal health and safety standards. For example, programs like the Animal Health Emergency Management (AHEM) initiative are focused on ensuring product safety, quality, and affordability while also addressing disease outbreak control, pathogen management, and the development of effective mitigation strategies.
In contrast, the Asia-Pacific region is anticipated to record the highest growth rate in the coming years. Rising disposable incomes and shifting consumer preferences in countries such as China, India, and Japan are leading to increased pet ownership and growing demand for veterinary services. In addition, the heightened consumption of meat, dairy, and poultry products is driving substantial investments in livestock healthcare, with a focus on vaccination, feed improvement, and preventative treatment measures.
Recent Developments:
- In Dec 2024, Zoetis Inc., introduced the Vetscan OptiCellTM, a novel screenless point-of-care hematological analyzer, to the world at the Veterinary Meeting & Expo (VMX) in January in Orlando, Florida. It is the first veterinary hematology diagnostic instrument that uses a cartridge and artificial intelligence (AI) to provide accurate insights in minutes through full blood count (CBC) analysis.
- In January 2024, Neogen Corporation declared the Provecta Pro Flea & Tick Collar for Dogs to be available. For dogs and pups 12 weeks of age and up, Provecta Pro provides easy and mess-free protection. Containing two active ingredients, Deltamethrin and the IGR (S)-Methoprene, Provecta Pro provides long-lasting, full-body protection against fleas, ticks, and mosquitoes* for six months.
- In November 2023, Virbac completed the acquisition of Globion’s majority interest. By expanding Virbac India’s current poultry offering into the expanding field of avian vaccines, this deal will strengthen position as India’s leader in animal health. The development, production, and marketing of live and inactivated vaccines that target a wide range of avian infections are areas in which Globion has established strong knowledge and competence.
Segmentation of Animal Health Market.
Global Animal Health Market- By Product
- Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesic
o Others
- Biologics
o Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Others
o Other Biologics
- Medicinal Feed Additives
- Diagnostics
o Consumables
o Instruments
- Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
- Others
o Veterinary Software
o Veterinary Telehealth
o Livestock Monitoring
Global Animal Health Market – By Animal
- Companion Animals
o Dogs
o Cats
o Horses
o Others
- Production Animals
o Cattle
o Swine
o Poultry
o Sheep & Goats
o Fish
Global Animal Health Market – By Distribution Channel
- Hospital/ Clinic Pharmacy
- Retail
- E-commerce
Global Animal Health Market – By End User
- Veterinary Hospitals & Clinics
- Veterinary Reference Laboratories
- Home Use
- Others
Global Animal Health Market – By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
